Role of helicobacters in neuropsychiatric disease: A systematic review in idiopathic parkinsonism

Rosalind M. Tucker, Aisha D. Augustin, Bu’ Hussain Hayee, Ingvar Bjarnason, David Taylor, Clive Weller, André Charlett, Sylvia M. Dobbs*, R. John Dobbs

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

5 Citations (Scopus)


Interest in an aetiopathogenic role for Helicobacter in neuropsychiatric diseases started with idiopathic parkinsonism (IP), where the cardinal signs can be assessed objectively. This systematic review, using an EMBASE database search, addresses Oxford Centre for Evidence-Based Medicine based questions on the inter-relationship of Helicobacter and IP, the benefits of eradicating Helicobacter in IP and the outcome of not treating. The search strategy was based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines: 21 of 204 articles met the inclusion criteria. The results show that the assumption that any benefit of Helicobacter eradication results from improved levodopa bioavailability is unjustified. The inter-relationship between Helicobacter and IP is well-established. H. pylori virulence markers (associated with autoimmunity and immune tolerance) influence the risk, severity and progression of IP. The birth cohort effect for virulence marker antibodies, seen in controls, is obliterated in IP, suggesting causality. Successful H. pylori eradication in IP is disease-modifying (even in anti-parkinsonian treatment-naïve patients) but not preventive. Hypokinesia regresses with eradication and overall motor severity lessens. Eradication may influence gastrointestinal microbiota adversely, unlocking the next stage in the natural history, the development of rigidity. Failed eradication worsens hypokinesia, as does the presence/persistence of H. pylori at molecular level only. Adequate prognostic assessment of the consequences of not treating Helicobacter, for IP, is prevented by a short follow-up. We conclude that Helicobacter is a pathophysiological driver of IP.

Original languageEnglish
Article number2159
Pages (from-to)1-24
Number of pages24
JournalJournal of Clinical Medicine
Issue number7
Publication statusPublished - Jul 2020


  • Aetiopathogenesis
  • Brady/hypokinesia
  • Eradication
  • Helicobacter pylori
  • Non-Helicobacter pylori Helicobacters
  • Parkinson’s disease
  • Rigidity
  • Virulence markers


Dive into the research topics of 'Role of helicobacters in neuropsychiatric disease: A systematic review in idiopathic parkinsonism'. Together they form a unique fingerprint.

Cite this